Lipid Microspheres for Biphenol Solubility and Oxidation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
2,2′,6,6′-tetraisopropyl-4,4′-biphenol, an anti-epileptic compound, is highly lipid soluble and difficult to dissolve in water, limiting its clinical application due to low solubility and efficacy, and is prone to oxidation, necessitating a stable and effective drug delivery method.
Innovation Solution
The development of 2,2′,6,6′-tetraisopropyl-4,4′-biphenol lipid microsphere preparations using phospholipid emulsifiers and antioxidants like vitamin E, encapsulating biphenol within lipid microspheres to enhance solubility, stability, and targeted drug delivery, while minimizing toxicity and side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If biphenol is used as an anti-epileptic compound, then therapeutic efficacy is improved, but solubility in water deteriorates
Solution Approach 1:
The patent uses lipid microspheres as an intermediary carrier to solubilize biphenol. The lipid microsphere composition includes phospholipids, triglycerides, and cholesterol that form a lipid-based carrier system capable of encapsulating the lipid-soluble biphenol compound, thereby enabling its delivery in aqueous environments without compromising solubility or efficacy
Solution Approach 2:
The patent changes the physical state and formulation parameters of biphenol by encapsulating it within lipid microsphere particles of specific size ranges (5-50 μm diameter). This particle formation transforms the dissolution behavior and enhances the apparent solubility while maintaining the active compound's therapeutic properties
2Reliability
If biphenol is used to treat epilepsy, then therapeutic effect is improved, but oxidation resistance deteriorates
Solution Approach 1:
The patent incorporates antioxidants (such as vitamin E, ascorbic acid, or their derivatives) into the lipid microsphere formulation before administering biphenol. This preemptive addition of antioxidants provides protective cushioning against oxidative degradation of biphenol during storage and in vivo circulation, ensuring compositional stability while maintaining therapeutic efficacy
Solution Approach 2:
The patent creates a composite lipid microsphere system combining multiple components: phospholipids, triglycerides, cholesterol, biphenol, and antioxidants. This composite structure provides both the solubilization matrix and the protective environment needed to prevent oxidation while delivering the therapeutic compound
3Quantity of substance
If conventional surfactants are used to increase biphenol dissolution, then solubility is improved, but cytotoxic side effects worsen
Solution Approach 1:
The patent replaces conventional synthetic surfactants with biocompatible, naturally-derived lipid components (phospholipids, triglycerides from vegetable oils, cholesterol) that form transient micellar or liposomal structures. These lipid carriers are metabolically compatible and non-toxic, providing temporary solubilization that is safely cleared by physiological processes without causing cytotoxicity
Solution Approach 2:
The patent changes the chemical nature of the solubilizing agent from synthetic surfactants to physiological lipids, and changes the aggregation state to form biocompatible micelles or liposomes. This parameter change in the carrier system maintains dissolution enhancement while eliminating the harmful cytotoxic effects associated with conventional surfactants
4Productivity
If lipid microsphere preparation is developed, then drug delivery efficiency is improved, but manufacturing complexity worsens
Solution Approach 1:
The patent employs preliminary action by pre-forming lipid microspheres using standardized methods (such as solvent evaporation, emulsion techniques, or high-pressure homogenization) before drug encapsulation. The lipid components are pre-mixed in specific ratios and pre-processed to ensure consistent particle formation, simplifying the overall manufacturing process while maintaining high drug delivery efficiency
Solution Approach 2:
The patent develops a universal lipid microsphere platform using common pharmaceutical excipients (phospholipids, triglycerides, cholesterol) that can encapsulate various lipid-soluble drugs. This multi-functional carrier system can be adapted to different active compounds through simple formulation adjustments, reducing manufacturing complexity while maintaining efficient drug delivery capabilities
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The lipid microsphere formulation significantly increases biphenol's solubility and stability, allows for higher drug concentration at targeted sites, reduces toxicity, and improves therapeutic efficacy compared to conventional preparations, with a stable and cost-effective production process suitable for mass production.
Implementation Method 1
0.5 ̃1% of antioxidants were added to the preparation to address the issue that biphenol is easily oxidizable. Particularly, vitamin E, a potent, lipid soluble antioxidant, is used for ensuring the stability of the drug in the preparation
Implementation Method 2
This invention uses only phospholipid emulsifiers in an amount of 1 to 1.5% without any co-solvent
Implementation Method 3
This invention uses only phospholipid emulsifiers in an amount of 1 to 1.5% without any co-solvent
Implementation Method 4
lipid microspheres are used as a drug carrier for the biphenol. This not only overcomes the problems due to insolubility of biphenol, but also allows the drug to be selectively accumulated in a lesion site
Data Source
AI summary
This invention relates to a 2,2′,6,6′-tetraisopropyl-4,4′-biphenol lipid microsphere preparation having 2,2′,6,6′-tetraisopropyl-4,4′-biphenol as its active ingredient and formed into said lipid microsphere preparation with common medically used injection-grade oil, emulsifier, and injection-grade water.